ArticleMolecular biology reports2026
Comparative phenotypic and molecular characterization of primary, sv40-immortalized, and commercial human corneal keratocytes reveals a passage-dependent optimal window for in vitro applications.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundKeratocyte cells residing in the corneal stroma produce extracellular matrix (ECM) proteins and support transparency. These cells are pivotal for corneal regeneration and the development of in vitro tissue substitutes. However, there is limited literature on the characteristics of primary and immortalized keratocyte cells. METHODS AND
resultsThis study investigates the preservation of keratocyte phenotype in primary cells isolated from human donors and their subsequent immortalized passages. Primary human corneal keratocyte cells (hKCs) isolated from donor corneas were immortalized using SV40. The differentiated expression of corneal and limbal genes in both primary hKC (at passage 2) and immortalized hKCs (at passages 9, 12, and 15) were evaluated using RT-PCR. Additionally, cells were examined using immunocytochemistry (ICC) with corneal keratocyte markers. The results demonstrate the presence of myofibroblast transformation in primary hKCs, while keratocyte characteristics remain intact even in subsequent passages of immortalized cells. The highest aquaporin 1 (AQP1), aldehyde dehydrogenase-3A1 (ALDH3A1), and collagen type I (COL1) expression was observed in immortalized hKC at passage 12.
conclusionsThese findings suggest that immortalized corneal keratocytes, are a viable source for corneal tissue engineering studies, particularly up to passage 12. The isolation, characterization, and immortalization of corneal keratocytes are imperative for further research and applications. Knowing the characteristics of keratocyte cells used in tissue engineering and therapeutic studies will significantly impact the outcomes.
Indexed as
Identifiers
42446752What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.